Category Archives: Uncategorized

Summer love; med tech ‘court-ship’ heats up

Louis Armstrong’s Summer Song evokes an inviting and mellow season, but a leisurely pace can be a pain in the neck for a med tech writer. The FDA’s device center might not be pumping out guidances of late, but the…

FacebookTwitterGoogle+Share

Philips set to acquire Spectranetics for $2.2B ahead of Stellarex approval

By Omar Ford, Staff Writer Royal Phillips NV is set to acquire Spectranetics Corp. for €1.9 billion ($2.2 billion). The proposed acquisition is the latest in a string of efforts the Amsterdam, the Netherlands-based company has made to strengthen its…

FacebookTwitterGoogle+Share

Glooko closes series C with $35M in financing to improve lives of patients with diabetes

By Katie Pfaff, Staff Writer Diabetes data management company Glooko closed a series C funding round with $35 million in financing, led by Georgian Partners. The Mountain View, Calif., company plans to use the funding to continue growth, including internationally,…

FacebookTwitterGoogle+Share

FDA approves first companion Dx for use with multiple NSCLC drugs

By Stacy Lawrence, Staff Writer The U.S. Food and Drug Administration has approved the Oncomine Dx Target Test from Thermo Fisher Scientific Inc. It is the first test of its kind to screen tumor samples for biomarkers associated with multiple…

FacebookTwitterGoogle+Share

Philips buying Oregon neuro EEG company Electrical Geodesics for €32.9M

By Stacy Lawrence, Staff Writer Royal Philips is slated to purchase Eugene, Ore.-based start up Electrical Geodesics Inc. to add its noninvasive brain activity monitoring and interpretation technology. The deal is expected to complement Philips existing imaging technology and neurological…

FacebookTwitterGoogle+Share

Senate health bill kills device tax, but tough sledding ahead

By Mark McCarty, Regulatory Editor The Senate health care reform bill debuted to a waiting and somewhat hostile Washington, and as expected, the legislation retains the repeal of the tax on medical devices and diagnostics found in the House bill….

FacebookTwitterGoogle+Share

Glaukos scores success with Istent Inject in study

By Omar Ford, Staff Writer Glaukos Medical Corp. is slowly proving its stent used in the treatment of glaucoma can be used as a standalone therapy, dispelling the idea the device must be used in conjunction with cataract procedures. The…

FacebookTwitterGoogle+Share

K2M finds its way through Sahara, looks to gain market share in spine

By Omar Ford, Staff Writer K2M Group Holdings Inc. is launching its Sahara Al Expandable stabilization system, the company’s first expandable offering within its interbody portfolio. Sahara adds more ammunition to the Leesburg, Va.-based company’s portfolio options and its bid…

FacebookTwitterGoogle+Share

Perkinelmer seeks to strengthen diagnostics position with $1.3B acquisition of Euroimmun

By Omar Ford, Staff Writer Perkinelmer Inc. has set its sights on beefing up its diagnostics offerings with a proposal to acquire Euroimmun Medical Laboratory Diagnostics AG, a private company, for $1.3 billion. If the deal goes through, then the…

FacebookTwitterGoogle+Share

Evasc gains C$10M series A round for pivotal U.S. trial of cerebral aneurysm clip

By Stacy Lawrence, Staff Writer Wide-neck bifurcations in cerebral aneurysms are among the most difficult to treat. Vancouver start up Evasc Neurovascular Enterprises ULC has developed the Eclips Aneurysm Remodeling System; it’s expected to offer a potential new standard-of-care, particularly…

FacebookTwitterGoogle+Share

Marketo